

#306 GenieUs: Selling big risk for big reward
Why do we know more about outer space than we do about our own brains?
GenieUs is a data science company that is on a mission to utilise the power of
the human genome to unlock new solutions for neurodegenerative diseases.
Matt Keon is the co-founder and CEO of biotech company GenieUs, alongside Sam Brennan PhD with research lead and supported by a world-class advisory board including Alan Robertson PhD, Professor Marcel Dinger PhD, and Dr Masha Strømme PhD.
Mark Bouris and Matt Keon discuss the commercialisation of data selling in science, the art of telling the story of an idea and leaning into trend.
Follow Mark Bouris on Instagram, LinkedIn & YouTube.
See omnystudio.com/listener for privacy information.
See omnystudio.com/listener for privacy information.